Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
Appropriate use criteria for imaging in nonvalvular heart disease released
- Author:
- Christopher Palmer
The document systematically reviews scenarios intended to reflect real-life situations.
News
Pembrolizumab approved for Merkel cell carcinoma
- Author:
- Christopher Palmer
The FDA granted accelerated approval for the drug based on promising results in nonrandomized, open-label trial.
News
A case of cold burn reported with whole-body cryotherapy
- Author:
- Christopher Palmer
A 71-year-old man presented with a cold burn injury a day after a cryotherapy session for back pain and arthritis.
News
Self-report of prenatal marijuana use not very reliable
- Author:
- Christopher Palmer
Umbilical cord testing showed higher prevalence of marijuana use than did self-report, even in a setting of...
News
Phase 3 study of novel pemphigus treatment is initiated
- Author:
- Christopher Palmer
Results of a phase 2 study of the BTK inhibitor were positive.
News
Firdapse approved: First treatment for rare autoimmune disorder
- Author:
- Christopher Palmer
Amifampridine (Firdapse) has been approved by the FDA for Lambert-Eaton myasthenic syndrome, which affects the nerves’ connection with muscles.
News
Temixys plus other antiretrovirals approved for HIV-1
- Author:
- Christopher Palmer
Temixys, a combination of 3TC and TDF, has been approved for pediatric and adult patients with HIV-1.
News
Comorbid depression, anxiety linked to doubled risk of diabetes
- Author:
- Christopher Palmer
“This study provides further support for the notion that depression with comorbid anxiety symptoms might represent a group...
News
Some statins worse than others for musculoskeletal adverse event onset time
- Author:
- Christopher Palmer
Concomitant nonstatin use doesn’t affect onset time of musculoskeletal adverse events.
News
Physical activity tied to lower depression risk among older adults
- Author:
- Christopher Palmer
“Meeting WHO recommended [physical activity] levels could be recommended ... to prevent the onset of depression.”
News
ICYMI: Alirocumab improves cardiovascular outcomes
- Author:
- Christopher Palmer
When used to treat patients after acute coronary syndrome, alirocumab had the greatest effect among patients...
News
FDA approves Sympazan for Lennox-Gastaut syndrome
- Author:
- Christopher Palmer
Patients with Lennox-Gastaut syndrome can have difficulty swallowing pills or large-volume oral suspensions, so this oral film may reduce care...
News
Age, insurance type tied to delay in pediatric febrile UTI treatment
- Author:
- Christopher Palmer
Longer delays in antimicrobial treatment can lead to renal scarring, which also is more likely with older age.
News
FDA approves DNA-based blood type test
- Author:
- Christopher Palmer
This is the first molecular-based test for red blood cell types to report genotypes in its results.
News
FDA approves emicizumab for hemophilia A without inhibitors
- Author:
- Christopher Palmer
Emicizumab-kxwh (Hemlibra) is now approved to treat all age groups with hemophilia A, with or without factor VIII inhibitors.